日本財団 図書館


2. Research Output
 In addition to judging United States competitiveness by comparing investments worldwide, the NNAP sought to compare research output. However, it is important to keep in mind that patents and publications are based on research that was performed one or more years prior to submission, with additional time elapsed between the submission of the research and its publication. Just as research spending precedes discovery and innovation, these measures lag behind.
 
2A. Publication Output
 One metric often used to gauge scientific leadership is the number of peer-reviewed scientific articles. Figure 2 shows the results of a search of one of the principal databases of scientific literature, the Institute for Scientific Information (ISI) Web of Science a searchable database of about 5400 professional journals, using the keyword "nano*." The chart shows an escalation in the total number of publications since 1989, and especially since 2000. Although the number of publications from the United States has grown throughout the period, the percentage of publications originating from the United States has declined from approximately 40% in the early 1990s to less than 30% in 2004. In a similar study, Zucker and Darby (2005) show that the United States is dominant in terms of the number of nanotechnology research articles published, accounting for more than twice the number published by the country with the next-highest number, China. However, Zucker and Darby also note that the U.S. share is decreasing. They summarize: "Taken as a whole these data confirm that the strength and depth of the American science base points to the United States being the dominant player in nanotechnology for some time to come, while the United States also faces significant and increasing international competition."
 
Figure 3.  Total Percentage of Articles in Science, Nature, and Physical Review Letters Identified by a Keyword Search on "nano*"
Source: J. Murday, U.S. Naval Research Laboratory
 
 Whereas the total number of publications is an indicator of the quantity of research output, a better indicator of the quality of the output is represented by publication in the most highly regarded and widely read scientific journals. A search of three high impact journals, Science, Nature, and Physical Review Letters, shows a 100% increase in the percentage of articles related to nanotechnology in these journals. Among these publications, the United States has produced an even larger fraction―over 50%―of the nanotechnology-related articles (Figure 3). These data show, however, as did those from the broader selection of publications, that there is a steady increase in the percentage that originates from other countries.
 
2B. Patent Output
 Another metric commonly used to gauge leadership in technology innovation, and one that is perhaps more indicative of movement toward a commercial application, is the number of patents and patent applications. A study by Huang et al. (2004) reveals the rapid growth of nanotechnology-related patents. Based on a search of the full text of patents in the U.S. Patent and Trademark Office (USPTO) database using a list of nanotechnology-related keywords, over 8,600 nanotechnology-related patents were issued in 2003, an increase of about 50% over the number issued in 2000. The analysis pointed to strong U.S. leadership in the number of patents issued. U.S. entities accounted for over 60% of nanotechnology patents recorded in the USPTO database during the years 1976 to 2003. In addition, among the patents identified by the study, U.S. patents received the most citations by subsequently filed patents, another indication of technology leadership. Overall, the five countries receiving the highest number of nanotechnology-related patents in 2003 were the U.S. (5,228), Japan (926), Germany (684), Canada (244) and France (183). The number of nanotechnology-related patents issued by the USPTO to assignees in other countries, especially the Netherlands, Korea, Ireland, and China, is likewise increasing.
 
 Because a full-text search finds patents that mention nanotechnology-related terms in the background section of the patent, even though the patented invention itself does not necessarily meet the definition of nanotechnology, Huang et al. also performed a search of just the patent title and claims. The results of this search for the years between 1990 and 2003 (shown in Figure 4) show trends that are similar to those indicated by the broader full-text search.
 
Nanocrystalline Synthetic Bone is Stronger and Heals Faster
 Every year, orthopedic surgeons will implant medical devices into millions of Americans to mend broken bones, repair ligaments and tendons, and relieve pain in backs, hips and knees. However, even the best materials and devices used today for such procedures are a compromise. Metal screws and pins can loosen or permanently weaken the surrounding bone white ordinary fillers or cements can be very slow to―or may never―fully heal.
 
 About half the weight of natural bone is the mineral hydroxyapatite, which makes a synthetic version of the mineral an obvious candidate for bone repair or replacement. Hydroxyapatite is in fact highly biocompatible. Bone cells attach to it and grow, and thereby encourage the healing process. But when manufactured using conventional methods, it forms a ceramic material with relatively large crystals compared to those in bones. The larger crystal size makes the synthetic material structurally weaker and less biocompatible than natural bone. Ceramic hydroxyapatite is made of many individual crystals packed together, and one way to make the material stronger and more biocompatible is by reducing the size of individual crystals.
 
 Research performed at MIT, and supported in part by the Office of Naval Research, has led to a technique for producing very pure, dense hydroxyapatite with crystals that are less than 100 nanometers across, similar to the size of hydroxyapatite crystals found in natural bone This synthetic bone nanomaterial more closely matches the strength of natural bone and, when used to fill voids caused by injury or disease, allows bones to heal faster and more completely than when coarser hydroxyapatite is used.
 
 In 2001, Angstrom Medica was founded to develop structural synthetic bone nanomaterials for medical use. Since then, the company has received several SBIR grants from the National Science Foundation and the National Institutes of Health and raised nearly $4 million in venture capital. In February 2005, Angstrom Medica received FDA approval to market its material for use as a bone void filler, making it the first engineered nanomaterial specifically cleared by FDA for medical use.
 
Photo courtesy of Angstrom Medica
 
 Angstrom Medica plans to take advantage of the mechanical strength of its dense, nanocrystalline hydroxyapatite to make orthopedic pins and screws (see photo) for applications like anchoring repaired ligaments, fusing spinal vertebrae, or pinning broken bones. Unlike metal screws, nanocrystalline hydroxyapatite implants should integrate fully with the natural bone, leaving it as good as new. And, as a side benefit, they won't set off the metal detectors at the airport!
 
Figure 4.  Number of Nanotechnology-related Patents Identified by a Search of Titles and Claims of Patents in the USPTO Database
Source: Huang, Z., H. Chen, Z.-K. Chen, and M. Roco. 2004. International Nanotechnology Development in 2003: Country, Institution, and Technology Field Analysis based on USPTO Patent Database. Journal of Nanoparticle Research, 6:325-354.
 
3. Research Areas of Focus
 The preceding sections indicate that the United States has a leadership position in terms of total investment, research publications, and patents related to nanotechnology. In addition to these overall measures, an accurate assessment of U.S. competitiveness requires the identification of countries that have adopted a strategy of making targeted investments, thereby positioning themselves to be leaders in a key industry or platform technology.
 
3A. Broad International Survey
 In June 2004, NSF sponsored an international meeting on responsible nanotechnology research and development at which 25 countries and the European Union were represented. Attendees were asked to provide estimates of government funding and areas of particular research interest. Results of this survey indicated that some nations have broad research programs, like the United States, whereas others have opted to make targeted research investments. Table 3 shows the key areas in which various countries are focusing their nanotechnology efforts according to the survey responses. These countries appear to be investing especially in materials/manufacturing, biotechnology, and electronics.
 
3B. Asia
 According to reports from the Asian Technology Information Program (ATIP), which tracks activity among Asian Pacific nations, China is especially strong in nanomaterials development. China's nanomaterials research focus, its low cost of doing business, its talented labor pool, and its potentially large domestic market, could provide incentive for further investment by foreign corporations seeking to capitalize on nanomaterials development (ATIP 2003; ATIP 2004). Other Asian countries are likewise focusing nanotechnology research efforts on industries in which they already hold a comparative advantage. According to ATIP, Korea is focusing on nanoelectronics with strong industry participation, Taiwan is targeting nanoelectronics, and Singapore has a particular emphasis on nanobiotechnology. Taiwan's National Science Council, which administers government funding for Taiwan's nanotechnology effort, plans to establish three technology research parks;
 
Table 3.  Focus Areas of Government Investments in Nanotechnology
Country Materials/ Manufact Devices (including Electronics & Optics) Energy & Environment Biotech/ Medical Instrument Development Education
Argentina X
Australia X X X X
Austria
Belgium X X X
Brazil X X X
Canada X X X
Czech Republic X X X
European Union* X X X X X X
France X X
Germany X X X X
India X X X X X
Ireland X X X X
Israel X X
Italy X X X X
Japan X X X X X
Korea X X
Mexico X
Netherlands X X X X
New Zealand X
Romania X X
South Africa X X X
Switzerland X X X X
Taiwan X X X
United Kingdom X X X
United States X X X X X X
Source: June 2004 International Dialogue on Responsible Research and Development of Nanotechnology,
http://www.nanoandthepoor.org/international.php
 
Note*: While the EU as a whole is pursuing a broad program, individual EU countries (also shown here) have more targeted areas of research.
 
 Two would focus on nanoelectronics research. Though Japan has the strongest government support for nanotechnology research in the region, with broad scope, its recognized strength is in infrastructure and instrumentation. Japan also is focused particularly on the commercialization of nanotechnology; recently a number of new initiatives were launched to assist Japanese businesses and to develop strategies aimed at creating new nanotechnology-related industries. As part of a larger S&T strategy, the Japanese government has included the "development of new devices using nanotechnology" as one of five "leading projects" aimed at revitalizing the Japanese economy.
 
Table 4.  German Federal Funding by Priority Sector (in Millions of Euros)
2002 2003 2004 2005
Nanoelectronics 19.9 25.0 44.7 46.2
Nanomaterials 19.2 20.3 32.7 38.1
Optical Science & Engineering 18.5 25.2 26.0 26.0
Microsystems Eng 7.0 7.0 9.4 10.2
Nanobiology 4.6 5.4 5.0 3.1
Communications 4.3 4.0 3.6 3.4
Other 0.4 1.3 2.4 2.2
Totals 73.9 88.2 123.8 129.2
Source: Roos, U. 2004, Germany's Nanotechnology Strategy. Berlin: British Embassy Berlin.
 
3C. Europe
 In Europe, efforts exist at both at the national level, with a number of individual countries pursuing targeted research, and at the European Commission (EC) level, with a more broad-based program. For example the EC, under its 6th Framework Programme for Research and Technological Development, committed about 350 million euros for nanotechnology funding in 2003, which represents a third of the overall European expenditure. In a recent communication (Commission of the European Communities 2004), the European Commission endorsed a more coordinated approach to nanotechnology R&D across EU countries while acknowledging the multiple individual country programs that already exist. Germany's strategic investment can be traced to the early 1990s, when nanotechnology was identified as a field with substantial promise. As a result of sector forecasting studies commissioned by the government, over the years Germany has developed a strategy to prioritize the majority of its Federal funding toward nanoelectronics, nanoscale materials, and optical science and engineering (OECD 2002; see also Table 4). In addition to funding for R&D, German public funding is targeting infrastructure development, including research centers at various geographic locations. While the EU as a whole appears to be competing for broad nanotechnology research leadership, some of the targeted research being conducted in particular EU countries could also provide competitive advantages in particular technologies or industry sectors. NNAP recommends the close monitoring of the EU's coordinated effort and the nanotechnology initiatives of individual EU countries.


前ページ 目次へ 次ページ





日本財団図書館は、日本財団が運営しています。

  • 日本財団 THE NIPPON FOUNDATION